KIDS
OrthoPediatrics corp

495
Mkt Cap
$441.36M
Volume
181,241.00
52W High
$27.60
52W Low
$15.28
PE Ratio
-9.00
KIDS Fundamentals
Price
$17.60
Prev Close
$18.33
Open
$18.33
50D MA
$17.48
Beta
1.20
Avg. Volume
204,827.79
EPS (Annual)
-$1.64
P/B
1.26
Rev/Employee
$364,282.92
Loading...
Loading...
News
all
press releases
OrthoPediatrics (NASDAQ:KIDS) Stock Rating Upgraded by Canaccord Genuity Group
Canaccord Genuity Group upgraded shares of OrthoPediatrics to a "strong-buy" rating in a research note on Wednesday...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
OrthoPediatrics (NASDAQ:KIDS) Upgraded by Wall Street Zen to "Hold" Rating
Wall Street Zen raised OrthoPediatrics from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·9d ago
News Placeholder
Brown Capital Management LLC Decreases Stake in OrthoPediatrics Corp. $KIDS
Brown Capital Management LLC lessened its holdings in OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) by 6.8% during the second quarter, according to its most recent 13F filing with the Securities...
MarketBeat·10d ago
News Placeholder
Wall Street Analysts Think OrthoPediatrics (KIDS) Could Surge 26.45%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 26.5% in OrthoPediatrics (KIDS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks·19d ago
News Placeholder
Wall Street Analysts Believe OrthoPediatrics (KIDS) Could Rally 41.92%: Here's is How to Trade
The consensus price target hints at a 41.9% upside potential for OrthoPediatrics (KIDS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks·1mo ago
News Placeholder
OrthoPediatrics (KIDS) Reports Q3 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for OrthoPediatrics (KIDS) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks·2mo ago
News Placeholder
OrthoPediatrics (KIDS) Reports Q3 Loss, Misses Revenue Estimates
OrthoPediatrics (KIDS) delivered earnings and revenue surprises of +7.69% and -2.14%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Will Glaukos (GKOS) Report Negative Earnings Next Week? What You Should Know
Glaukos (GKOS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·2mo ago
News Placeholder
Earnings Preview: OrthoPediatrics (KIDS) Q3 Earnings Expected to Decline
OrthoPediatrics (KIDS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·2mo ago
News Placeholder
OrthoPediatrics (KIDS) Reports Q2 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for OrthoPediatrics (KIDS) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks·4mo ago

Latest KIDS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.